Serna BioMapping the druggable transcriptome

Serna Bio | AI Enabled RNA Drug Discovery

Mapping the Druggable Transcriptome

An estimated 85% of the ~3 billion base pairs in the human genome is transcribed into RNA, but only ~1.5% of these code for proteins. While the chemical properties of protein binders are increasingly understood, the field of RNA-targeted drugs is relatively new. The properties of small molecules that drive specific and selective targeting of RNA, and associated assays, are yet to be developed.

Key Features

• AI-enabled, data-first approach to RNA-small molecule interactions
• Discovery Platform for first-in-class small molecule programs
• Targeting classically undruggable proteins and non-coding RNA targets
• Focus on both human and non-human biology
• Building the world's first map of the druggable transcriptome

Use Cases

• Development of RNA-targeted drugs
• Research on non-coding RNA targets
• Exploration of classically undruggable proteins
• Advancing the understanding of RNA-small molecule interactions
• Application in both human and non-human biological research

Pricing

For detailed pricing information, please contact us at [email protected].

Teams

At Serna Bio, we are always pushing the frontier of what is known. Our team is dedicated to building the world's first map of the druggable transcriptome. We are proud of our achievements and love sharing our knowledge with the community. Our news section includes information about our latest publications, events, and business analysis.